Bruker Corp Files 8-K for Regulatory Disclosure
Ticker: BRKRP · Form: 8-K · Filed: May 2, 2024 · CIK: 1109354
| Field | Detail |
|---|---|
| Company | Bruker Corp (BRKRP) |
| Form Type | 8-K |
| Filed Date | May 2, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, regulatory-disclosure
Related Tickers: BRKR
TL;DR
Bruker Corp filed a routine 8-K. No major news.
AI Summary
Bruker Corporation filed an 8-K on May 2, 2024, to report on a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements for this type of form.
Why It Matters
This filing indicates Bruker Corporation is adhering to its reporting obligations with the SEC, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for regulatory disclosure and does not contain any new material information that would inherently increase risk.
Key Players & Entities
- Bruker Corporation (company) — Registrant
- 0000950170-24-051559 (filing_id) — Accession Number
- May 02, 2024 (date) — Report Date
- 40 Manning Road, Billerica, MA 01821 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Regulation FD Disclosure and Financial Statements and Exhibits, as indicated in the filing details.
What is the exact date of the report?
The exact date of the report is May 02, 2024.
What is Bruker Corporation's principal executive office address?
Bruker Corporation's principal executive office is located at 40 Manning Road, Billerica, MA 01821.
What is the Commission File Number for Bruker Corporation?
The Commission File Number for Bruker Corporation is 000-30833.
Does this filing announce any new financial results or material events?
Based on the provided text, this filing is for standard regulatory disclosure (Regulation FD, Financial Statements and Exhibits) and does not explicitly announce new financial results or specific material events.
Filing Stats: 523 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-05-02 07:00:10
Key Financial Figures
- $0.01 — nge on Which Registered Common Stock, $0.01 par value per share BRKR The Nasdaq
Filing Documents
- brkr-20240502.htm (8-K) — 45KB
- brkr-ex99_1.htm (EX-99.1) — 17KB
- img53376846_0.jpg (GRAPHIC) — 12KB
- 0000950170-24-051559.txt ( ) — 198KB
- brkr-20240502.xsd (EX-101.SCH) — 29KB
- brkr-20240502_htm.xml (XML) — 4KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure On May 2, 2024, Bruker Corporation (the "Company") issued a press release announcing the closing of the acquisition of all the issued and outstanding securities of TecInvest S. r.l, which does business as ELITechGroup. A copy of the press release is attached hereto as Exhibit 99.1. The information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. Section 9 – Financial Statements and Exhibits
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Number Description 99.1 Press release dated May 2, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BRUKER CORPORATION (Registrant) Date: May 2, 2024 By: /s/ GERALD N. HERMAN Gerald N. Herman Executive Vice President and Chief Financial Officer